While providing local GI benefits, BPC-157 demonstrates systemic bioavailability after oral administration, distributing throughout the body to support healing in joints, tendons, muscles, and other tissues
Data on study type (e.g., randomized controlled trial (RCT), randomized crossover trial, observational study), treatment parameters (e.g., dose, administration protocols, follow-up durations), patient characteristics (i.e., age, gender, symptom duration), AEs, and primary outcomes (as defined by study authors) were extracted
Chronic Spine Pain: Whether from disc degeneration, facet joint disease, or muscular dysfunction, peptides can address the underlying tissue pathology contributing to persistent back and neck pain
Bpc-157 increases actin gene expression while Tb-500 sequesters and organizes the resulting actin for optimal cell movement